The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...

Researcher Gary Gibson talks at Burke in White Plains about a trial on a new treatment for Alzheimer’s that uses Benfotiamine ...

ProJenX and Unlearn partnered to implement genAI technology for a Phase I trial of prosetin for amyotrophic lateral sclerosis ...

For clinical research to be truly reflective of our populations, DEI-oriented strategies need to take higher priority in ...

Researchers from Stanford University and Rensselaer Polytechnic Institute have developed an advanced AI model that improves ...

Results of a world-first phase 3 trial for secondary progressive multiple sclerosis (MS), led by UCL researchers, have shown ...

Prostate cancer disproportionately affects Black men, leading to higher mortality rates and worse health outcomes compared to ...

The partnership will employ the ALS-Digital Twin Generator of Unlearn to enhance the trial's evaluation process.

Clinical packaging and labelling follow stringently controlled procedures and high-standard quality control measures to assure the safety and functionality of investigational medicinal products, ...

Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission ...

Pharma leaders need to consider the lack of diversity in clinical trial findings and the resulting dearth of therapies ...

Vivani Medical receives approval for the first human trial of its GLP-1 obesity implant in Australia. The LIBERATE-1 trial ...